Friday, 15 Nov 2019

You are here

Poll: Americans Favor Federal Action on Drug Prices

Most Americans value the prescription products the drug industry produces, but they sure don't like the prices and want the federal government to take action, according to a new survey.

Just over half of Americans (54%) are currently taking a prescription drug. While most say their drugs are easy to afford, consumers in general (72%) believe drug costs are unreasonable, according to the poll by the Kaiser Family Foundation. (Kaiser Health News is an editorially independent part of the foundation.)

More people (51%) think competition would do a better job of controlling prices than federal regulation (40%). But large majorities said they would favor allowing Medicare to negotiate with companies on prices and allowing people to buy medicines imported from Canada.

Prescription prices have come under scrutiny as even some people with insurance struggle with the costs, particularly for some drugs for cancer and other hard to treat illnesses. The health insurance industry has mounted a major public relations campaign on the issue, countered by pharmaceutical industry claims that drugs can drastically reduce the need for other health spending like hospital stays.

The KFF poll, conducted by phone Aug. 6-11, used a nationally representative sample of 1,200 adults. The margin of error is plus or minus 3 percentage points.

-- This article is brought to our readers by our friends at MedPage Today. It was originally published on August 20, 2015 

This article is brought to RheumNow Readers by our friends at MedPage Today. The article, which first appeared Aug. 20, 2015, was reprinted from kaiserhealthnews.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonprofit, nonpartisan health policy research and communication organization not affiliated with Kaiser Permanente.

 

Disclosures: 
The author has no conflicts of interest to disclose related to this subject

Add new comment

More Like This

Rise in Fatty Liver Disease Linked to Obesity and Diabetes

Gut has published population results from NHANES population study showing that the prevalence of fatty liver disease is rising in the US and is driven by obesity and diabetes.

Employed Physicians Outnumber Self-Employed

For the first time in the United States, employed physicians outnumber self-employed physicians, according to a newly updated study on physician practice arrangements by the American Medical Association (AMA). This milestone marks the continuation of a long-term trend that has slowly shifted the distribution of physicians away from ownership of private practices.

 

Dr. Harold E. Paulus (1929-2019)

Dr. Harold “Hal” Paulus lives in the annals of Rheumatology as a major contributor, mentor, researcher and clinical trialist. He passed away last week, one day after his 89th birthday. I met Dr. Paulus as a fellow in 1985, when he easily included me in his discussions and research on rheumatoid arthritis. I admired his easy demeanor, wry humor and every man character. Most remark on his calm recessive and kind personality that was complemented by a body of work that was large, impactful and usually at the cutting edge. Many of Dr. Paulus’ colleagues and friends have contributed their testimonies and fond memories of this great man.

RheumNowLive On Demand: The History of Steroids - Dr. Eric Matteson

A clip from RheumNow Live On Demand. You can access the full library of content from the meeting.

Mourning the Loss of NIAMS Director Stephen Katz, MD, PhD

The following tribute to the late Dr. Steven Katz appeared on the NIH website.